3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome. [electronic resource]
Producer: 20110524Description: 867-74 p. digitalISSN:- 1744-8409
- 4-Aminopyridine -- adverse effects
- Action Potentials -- drug effects
- Amifampridine
- Calcium Channels -- metabolism
- Cholinergic Agents -- adverse effects
- Clinical Protocols
- Epilepsy -- etiology
- Humans
- Lambert-Eaton Myasthenic Syndrome -- drug therapy
- Muscles -- drug effects
- Paresthesia -- etiology
- Presynaptic Terminals -- drug effects
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.